Screening of Anemia in Patients with Coronary Heart Disease in Outpatient Practice Using a Computer Monitoring System

Alexey Y. Simion, Andrey V. Budnevsky, Evgeniy S. Ovsyannikov, Natalia E. Nekhaenko, Nadezhda I. Ostroushko, Natalia V. Malyukova

 
International Journal of Biomedicine. 2022;12(3):355-359.
DOI: 10.21103/Article12(3)_OA1
Originally published September 5, 2022

Abstract: 

The aim of this study was to assess the prevalence, structure, and influence of anemic syndrome on the main health indicators of patients with coronary heart disease (CHD), including the main QOL parameters.
Methods and Results: The study included 1210 patients (309 men and 901 women) with an average age of 67.57±9.35 years who were registered at the dispensary with CHD (angina pectoris CCSA classes II-IV) in 2 Regional Hospitals. With the help of the computer program “Monitoring system for patients with anemia syndrome,” medical records from 2 randomly selected primary care areas were analyzed. The data directly related to anemia, comorbid pathology, and previous treatment formed the main part of the statistical data. The QOL was evaluated using the 36-Item Short Form Survey (SF-36) questionnaire. The FACT-An questionnaire was used to account for the characteristic symptoms, and their severity, accompanying anemia.
Our findings indicate the presence of anemia in 500(41.3%) patients (355/71% women and 145/29% men). The average age of the patients with diagnosed anemia was 65.34±6.37 years in men and 63.49±7.05 years in women. Anemia of mild severity was observed in 410(82%) patients, moderate severity in 75(15%) patients, and severe anemia in 15(3%) patients. IDA was detected in 467(93.4%) cases and B12-deficiency anemia in 33(6.6%) cases. We found a negative correlation between the blood iron level and age (r=-0.56, P<0.05), which can indirectly indicate the progression of latent iron deficiency with age in CHD patients.
All 500 CHD patients with anemia were included in Group 1. Group 2 included 710 CHD patients without anemia. In Groups 1 and 2, angina severity according to CCSA classification was as follows: CCSA class II - 186(37.2%) and 456(64.2%) cases (P=0.000), CCSA class III – 248(49.6%) and 196(27.6%) cases (P=0.000), and CCSA class IV - 66(13.2%) and 58(8.2%) cases (P=0.005), respectively. Group 1 patients, in contrast to Group 2 patients, had the following characteristic clinical features: palpitation (48.2% vs. 35.0%, P=0.000), higher HR (81±9.5 bpm vs. 71.8±8.7 bpm, P=0.000) and respiratory rate (18.9±1.1 vs 18.3±1.2 per minute, P=0.000).
The assessment of the impact of anemia on QOL by FACT-An revealed a statistically lower score in Group 1 than in Group 2 (32.0±5.7 vs. 44.0±6.5, P=0.000). We found a positive correlation between the Hb level and the average FACT-An score (r=0.54, P<0.05) Patients in Group 1 demonstrated a low level of QOL in the physical and mental domains, according to SF-36, in comparison with Group 2. Correlation analysis revealed a direct relationship between the Hb level and the average score of the PF (physical functioning) scale (r=0.52, P<0.05)) and PCS (physical component summary) (r=0.38, P<0.05)) of the SF-36 questionnaire.
The observed high incidence of anemic syndrome in CHD patients with angina pectoris (CCSA class II-IV) requires special attention due to the high impact on the QOL of patients and aggravation of the course of the underlying disease.

Keywords: 
anemia • сoronary heart disease • quality of life
References: 

1. Cascio MJ, DeLoughery TG. Anemia: Evaluation and Diagnostic Tests. Med Clin North Am. 2017 Mar;101(2):263-284. doi: 10.1016/j.mcna.2016.09.003. Epub 2016 Dec 8. PMID: 28189170.
2. de Las Cuevas Allende R, Díaz de Entresotos L, Conde Díez S. Anaemia of chronic diseases: Pathophysiology, diagnosis and treatment. Med Clin (Barc). 2021 Mar 12;156(5):235-242. English, Spanish. doi: 10.1016/j.medcli.2020.07.035. Epub 2020 Dec 24. PMID: 33358297.
3. Merlo CM, Wuillemin WA. Diagnostik und Therapie der Anämie in der Praxis [Diagnosis and therapy of anemia in general practice]. Praxis (Bern 1994). 2009 Feb 18;98(4):191-9. doi: 10.1024/1661-8157.98.4.191. PMID: 19224487. [Article in German].
4. Paul B, Wilfred NC, Woodman R, Depasquale C. Prevalence and correlates of anaemia in essential hypertension. Clin Exp Pharmacol Physiol. 2008 Dec;35(12):1461-4. doi: 10.1111/j.1440-1681.2008.05031.x. Epub 2008 Aug 26. PMID: 18759858.
5. Pasricha SR. Anemia: a comprehensive global estimate. Blood. 2014 Jan 30;123(5):611-2. doi: 10.1182/blood-2013-12-543405. PMID: 24482500.
6. Lanier JB, Park JJ, Callahan RC. Anemia in Older Adults. Am Fam Physician. 2018 Oct 1;98(7):437-442. PMID: 30252420.
7. Budnevsk AV, Simeon AY, Shapovalova MM. [Pathophysiology of anemic syndrome in cardiovascular diseases]. Nauka Molodykh (Eruditio Juvenium). 2021; 9(2):301-312. [Article in Russian].
8.Budnevsky AV, Pronin SS, Voronina EV, Kontsevaya AV, Korotkov IN, Natarov AA, et al. Computer program No. 2019665676 Russian Federation / Monitoring system of the therapeutic and diagnostic process in patients with anemia. Published on 27.11.2019. Application No. 2019664783 dated 21.11.2019. [In Russian]
9. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assess-ment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2013 (WHO/NMH/NHD/MNM/11.1)
10.Campeau L. Letter: Grading of angina pectoris. Circulation. 1976 Sep;54(3):522-3. PMID: 947585.
11. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.
12. Gandra SR, Finkelstein FO, Bennett AV, Lewis EF, Brazg T, Martin ML. Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: a systematic review. Am J Kidney Dis. 2010 Mar;55(3):519-34. doi: 10.1053/j.ajkd.2009.09.019. Epub 2009 Dec 23. PMID: 20031287.
13.Weisbord SD, Fried LF, Mor MK, Resnick AL, Unruh ML, Palevsky PM, Levenson DJ, Cooksey SH, Fine MJ, Kimmel PL, Arnold RM. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol. 2007 Sep;2(5):960-7. doi: 10.2215/CJN.00990207. Epub 2007 Aug 8. PMID: 17702730.
14.Cella D. The functional assessment of Cancer therapy-Anemia (FACT-an) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol. 1997;34(3 Suppl 2):13–9.
15.Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997 Feb;13(2):63-74. doi: 10.1016/s0885-3924(96)00274-6. PMID: 9095563.
16.Finkelstein FO, van Nooten F, Wiklund I, Trundell D, Cella D. Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease. Health Qual Life Outcomes. 2018 May 31;16(1):111. doi: 10.1186/s12955-018-0933-8. PMID: 29855366; PMCID: PMC5984470.
17. Farag YM, Keithi-Reddy SR, Mittal BV, Surana SP, Addabbo F, Goligorsky MS, Singh AK. Anemia, inflammation and health-related quality of life in chronic kidney disease patients. Clin Nephrol. 2011 Jun;75(6):524-33. doi: 10.5414/cnp75524. PMID: 21612756.
18.Ferrari M, Manea L, Anton K, Bruzzone P, Meneghello M, Zamboni F, Purgato L, Cazzoletti L, Ferrari P, Testi R. Anemia and hemoglobin serum levels are associated with exercise capacity and quality of life in chronic obstructive pulmonary disease. BMC Pulm Med. 2015 May 8;15:58. doi: 10.1186/s12890-015-0050-y. PMID: 25952923; PMCID: PMC4426177.
19.Wasada I, Eguchi H, Kurita M, Kudo S, Shishida T, Mishima Y, Saito Y, Ushiorozawa N, Seto T, Shimozuma K, Morita S, Saito M, Yokomizo Y, Ishizawa K, Ohashi Y, Eguchi K. Anemia affects the quality of life of Japanese cancer patients. Tokai J Exp Clin Med. 2013 Apr 20;38(1):7-11. PMID: 23564569.
20. Kraai IH, Luttik ML, Johansson P, De Jong RM, Van Veldhuisen DJ, Hillege HL, Jaarsma T. Health-related quality of life and anemia in hospitalized patients with heart failure. Int J Cardiol. 2012 Nov 29;161(3):151-5. doi: 10.1016/j.ijcard.2012.05.036. Epub 2012 May 28. PMID: 22647414.
21.Dharmarajan TS, Norkus EP. Mild anemia and the risk of falls in older adults from nursing homes and the community. J Am Med Dir Assoc. 2004 Nov-Dec;5(6):395-400. doi: 10.1097/01.JAM.0000144734.84172.89. PMID: 15530178.
22. Kamenetz Y, Beloosesky Y, Zeltzer C, Gotlieb D, Magazanik A, Fishman P, Grinblat J. Relationship between routine hematological parameters, serum IL-3, IL-6 and erythropoietin and mild anemia and degree of function in the elderly. Aging (Milano). 1998 Feb;10(1):32-8. doi: 10.1007/BF03339631. PMID: 9589749.
23. Wouters HJCM, van der Klauw MM, de Witte T, Stauder R, Swinkels DW, Wolffenbuttel BHR, Huls G. Association of anemia with health-related quality of life and survival: a large population-based cohort study. Haematologica. 2019 Mar;104(3):468-476. doi: 10.3324/haematol.2018.195552. Epub 2018 Oct 11. PMID: 30309850; PMCID: PMC6395328.
24.Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR. Impact of anemia on hospitalization and mortality in older adults. Blood. 2006 May 15;107(10):3841-6. doi: 10.1182/blood-2005-10-4308. Epub 2006 Jan 10. PMID: 16403909.
25.Penninx BW, Pahor M, Woodman RC, Guralnik JM. Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci. 2006 May;61(5):474-9. doi: 10.1093/gerona/61.5.474. PMID: 16720744.
26. Halawi R, Moukhadder H, Taher A. Anemia in the elderly: a consequence of aging? Expert Rev Hematol. 2017 Apr;10(4):327-335. doi: 10.1080/17474086.2017.1285695. Epub 2017 Feb 2. PMID: 28110585.

Download Article
Received July 7, 2022.
Accepted August 10, 2022.
©2022 International Medical Research and Development Corporation.